Does RIOCIGUAT Cause Infusion site erythema? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Infusion site erythema have been filed in association with RIOCIGUAT (Adempas). This represents 0.4% of all adverse event reports for RIOCIGUAT.
80
Reports of Infusion site erythema with RIOCIGUAT
0.4%
of all RIOCIGUAT reports
6
Deaths
42
Hospitalizations
How Dangerous Is Infusion site erythema From RIOCIGUAT?
Of the 80 reports, 6 (7.5%) resulted in death, 42 (52.5%) required hospitalization, and 2 (2.5%) were considered life-threatening.
Is Infusion site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Infusion site erythema?
TREPROSTINIL (2,990)
HUMAN IMMUNOGLOBULIN G (1,850)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (312)
AMBRISENTAN (308)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (213)
FOSCARBIDOPA\FOSLEVODOPA (157)
MACITENTAN (147)
EPOPROSTENOL (90)
LECITHIN\POLOXAMER 407 (70)
INFLIXIMAB-DYYB (62)
Which RIOCIGUAT Alternatives Have Lower Infusion site erythema Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE